A novel single step double positive double negative selection strategy for beta-globin gene replacement.
beta-Thalassemias are a heterogeneous group of autosomal recessive disorders, characterized by reduced or absence of the beta-globin chain production by the affected alleles. Transplantation of genetically corrected autologous hematopoietic stem cell (HSC) is an attractive approach for treatment of these disorders. Gene targeting (homologous recombination) has many desirable features for gene therapy due to its ability to target the mutant genes and restore their normal expression. In the present study, a specific gene construct for beta-globin gene replacement was constructed consisting of: two homologous stems including, upstream and downstream regions of beta-globin gene, beta-globin gene lying between hygromycin and neomycin resistant genes as positive selection markers and thymidine kinase expression cassettes at both termini as negative selection marker. All segments were subcloned into pBGGT vector. The final plasmid was checked by sequencing and named as pFBGGT. Mammalian cell line COS-7 was transfected with linear plasmid by lipofection followed by positive and negative selection. DNA of the selected cells was analyzed by PCR and sequencing to confirm the occurrence of homologous recombination. In this novel strategy gene replacement was achieved in one step and by a single construct.
Khanahmad
H
H
Biotechnology Research Centre, Pasteur Institute of Iran, Tehran, Iran.
Noori Daloii
M R
MR
Shokrgozar
M A
MA
Azadmanesh
K
K
Niavarani
A R
AR
Karimi
M
M
Rabbani
B
B
Khalili
M
M
Bagheri
R
R
Maryami
F
F
Zeinali
S
S